LAMP
Inflammatix Raises $57M in Series E Financing
The company said that it will use the money to support regulatory filings and commercialization of its 30-minute TriVerity Acute Infection and Sepsis Test.
The Paris-based startup plans to use €1.5 million in pre-seed funding to support R&D on a test kit and deliver preclinical data by early 2025.
Startup En Carta Gets €1.5M for Development of Lyme Disease Test
The Paris-based firm will use the money to support the development of its Lyme disease test kit that will be used for early detection following a tick bite.
The firm has updated its low-cost Hub instrument and pivoted its testing menu toward multiplex point-of-care panels.
Sekisui Diagnostics, Aptitude Medical Systems Sign US Distribution Deal for POC COVID Test
Aptitude's assay is designed to detect SARS-CoV-2 in self-collected saliva or anterior nasal swab samples, providing results via a paired reader in 30 minutes.